Salvus Wealth Management LLC Has $422,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Salvus Wealth Management LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 21.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 835 shares of the healthcare conglomerate’s stock after selling 234 shares during the period. Salvus Wealth Management LLC’s holdings in UnitedHealth Group were worth $422,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $27,000. Global Wealth Strategies & Associates raised its position in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares in the last quarter. West Financial Advisors LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $32,000. Quarry LP raised its holdings in shares of UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares during the period. Finally, RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group during the third quarter worth about $37,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 6.0 %

NYSE UNH opened at $511.02 on Friday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The business has a fifty day moving average price of $553.38 and a two-hundred day moving average price of $562.98. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The stock has a market capitalization of $470.28 billion, a PE ratio of 33.29, a PEG ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.83 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.64%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday. Oppenheimer upped their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Piper Sandler reduced their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Finally, Cantor Fitzgerald boosted their price target on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. Two investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and three have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $626.79.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.